Drug patent lawsuits for ZUBSOLV.
DrugPatentWatch. Originally released at
New patent for Orexo Us drug ZUBSOLVAnnual Drug Patent Expirations for ZUBSOLV
This drug has forty patent member of the family in twenty-eight nations.
The generic ingredient in ZUBSOLV is buprenorphine hydrochloride; naloxone hydrochloride. Extra information are available on the buprenorphine hydrochloride; naloxone hydrochloride profile page.
To learn more on how DrugPatentWatch can assist with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
ZUBSOLV drug cost trends.
Zubsolv is a drug marketed by Orexo Us Inc and is consisted of in one NDA. There are 5 patents protecting this drug and 4 Paragraph IV difficulties.
Make Better Decisions with DrugPatentWatch
Get the Daily Briefing or Try a trial
DrugPatentWatch. Initially released at
New patent for Orexo Us drug ZUBSOLV